Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;16(4):1019-1033.
doi: 10.1007/s12105-022-01457-2. Epub 2022 May 4.

Combined Neuroendocrine and Squamous Cell Carcinoma of the Sinonasal Tract: A Morphologic and Immunohistochemical Analysis and Review of Literature

Affiliations
Review

Combined Neuroendocrine and Squamous Cell Carcinoma of the Sinonasal Tract: A Morphologic and Immunohistochemical Analysis and Review of Literature

Shweta Agarwal et al. Head Neck Pathol. 2022 Dec.

Abstract

Sinonasal malignancies constitute 3% of head and neck cancers, with squamous cell carcinoma (SCC) the most common histology. Neuroendocrine carcinomas (NEC) are rare, with a subset showing neuroendocrine carcinoma and a non-neuroendocrine component. The pathogenesis of these combined tumors is largely unknown, and TP53 driver mutations may play a role. A database search for combined NEC was performed across two institutions (UNM and UCSF) spanning 15 years. Excluding NUT midline carcinoma, 3 cases met inclusion criteria. All were morphologically NEC + SCC and underwent a comprehensive immunohistochemical evaluation. Tumors demonstrated two components histologically: moderately to poorly differentiated SCC and high-grade NEC. Divergent differentiation was confirmed with lineage-specific markers. Only one patient received neoadjuvant chemotherapy prior to surgery, with a remarkable response (a marked decrease in the size of the primary lesion and resolution of liver metastases). Immunohistochemical staining for p53 was increased in 2 of 3 cases (both components), suggesting a role in the carcinogenesis of these tumors. Aberrant expression of beta-catenin was not identified. One case tested positive for p16, which can be seen in high grade NECs due to inactivation of Rb gene. Additionally, both cases with a small cell NEC component expressed PD-L1, suggesting that immunotherapy may be an effective treatment. Findings in this study support the role of p53 mutation in a subset of combined NEC + SCC of the sinonasal tract. Recognition of this rare entity is essential for optimal management of these aggressive neoplasms.

Keywords: Carcinoma; Combined; Neuroendocrine; Squamous cell; TP53; p53.

PubMed Disclaimer

Conflict of interest statement

No disclosures.

Figures

Fig. 1
Fig. 1
Case 1 (Clinical and morphology) A CT with contrast shows a 4.1 cm mass in the right maxillary sinus; B, C Fine needle aspirate smear showed small blue cell morphology, Diff-Quick (C Inset shows the small blue cell clusters in the cell block, H&E); D Presurgical biopsy shows a moderately differentiated squamous cell carcinoma, H&E; E Histologic section from the resection specimen (post neo-adjuvant therapy) showing both squamous cell and neuroendocrine components, H&E; F High power view of the more basaloid appearing squamous cell component in the resection specimen, H&E; G High power view of the small cell NEC component in the resection specimen, H&E. Magnification in B is ×10; C is ×40; D, F, G is ×20; and E is ×4
Fig. 2
Fig. 2
Case 1 (IHC) A CK5/6-p40 (cocktail stain) and p63 (B, inset) stain the squamous cell carcinoma component; C and D Chromogranin and CD56 (respectively) stain the small cell NEC component; E Tumor showed high expression of p53. Magnification in A, B and E is ×4 while C and D is ×10
Fig. 3
Fig. 3
Case 2 A Maxillofacial CT showed opacification of the left maxillary sinus; B High power view of the moderately differentiated SCC component, H&E; C High power view of the large cell NEC component; D p53 expression. Magnification in B and C is ×20 and D is ×10
Fig. 4
Fig. 4
Case 2 A Combined SCC and NEC juxtaposed, H&E (Black arrows: SCC, Red arrow: NEC); B and C p63 and CK5/6 expression in SCC component (respectively); D Synaptophysin (weak) expression in NEC. Magnification in AD is ×10
Fig. 5
Fig. 5
Case 3 A A post biopsy CT showed residual tumor involving the left inferior turbinate and medial wall of the left maxillary sinus; B High power view of the SCC component, H&E; C High power view of the small cell NEC component, H&E; D p16 expression; E HPV hr ISH; F p53 expression. Magnification in B, C, and F is ×20 while D and E is ×10
Fig. 6
Fig. 6
Case 3 A Combined SCC and NEC juxtaposed, H&E (Black arrows: SCC, Red arrow: NEC); B and C p63 and CK5/6 expression in SCC component (respectively); D Synaptophysin (weak) expression in NEC. Magnification in AD is ×10
Fig. 7
Fig. 7
A Representative image of PD-L1 expression (Case 1); B Representative image of Beta-catenin (Case 1). Magnification in both A and B is ×10

References

    1. Youlden DR, Cramb SM, Peters S, et al. International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol. 2013;37(6):770–779. doi: 10.1016/j.canep.2013.09.014. - DOI - PubMed
    1. Dutta R, Dubal PM, Svider PF, et al. Sinonasal malignancies: a population-based analysis of site-specific incidence and survival. Laryngoscope. 2015;125(11):2491–2497. doi: 10.1002/lary.25465. - DOI - PubMed
    1. Bishop JA, Guo TW, Smith DF, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2):185–192. doi: 10.1097/PAS.0b013e3182698673. - DOI - PMC - PubMed
    1. Bishop JA. Newly described tumor entities in Sinonasal Tract Pathology. Head Neck Pathol. 2016;10(1):23–31. doi: 10.1007/s12105-016-0688-7. - DOI - PMC - PubMed
    1. Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34(6):877–885. doi: 10.1002/hed.21830. - DOI - PubMed

Substances